Ono Licenses Sapablursen from Ionis for Polycythemia Vera
Ono Pharmaceutical Co., Ltd. announced that it has entered into a license agreement with Ionis Pharmaceuticals, Inc. for sapablursen, an investigational RNA-targeted medicine for the...
Tag : financial results
AXA XL announces new leadership for North America Insurance Programs
AXA XL has appointed Simon Rees as Chief Underwriting Officer, North America Programs. Currently the Chief Reserving Actuary for the Americas, Mr. Rees assumes his new role on April...
CVOW Project Stays on Track, Updates Cost to Meet Energy Demand
Dominion Energy, Inc., provided several updates for the Coastal Virginia Offshore Wind (CVOW) project. The 2.6 GW, fully permitted project is now approximately 50% complete...